Nephron Sc Inc recalls Ketorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL), packaged in 2 mL single dose vials, Rx Only, Nephron Pharma
Recalled August 24, 2022 · FDA recall D-1354-2022 · Nephron Sc
Hazard
cGMP Deviations: deviations leading to potential cross-contamination. · FDA Class II
Units
5040 vials
Sold at
USA Nationwide
Description
cGMP Deviations: deviations leading to potential cross-contamination.
Product
Ketorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL), packaged in 2 mL single dose vials, Rx Only, Nephron Pharmaceutical Corporation 4500 12th Street Extension West Columbia, SV 29172, NDC 0487-6232-01
Manufacturer(s)
Nephron Sc Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →